[ Pobierz całość w formacie PDF ]
thromycin blocks the rapid component of the delayed rectifier 2 9.
potassium current and lengthens repolarization of guinea pig 43. Heykants J, Hendriks R, Meuldermans W, Michiels M,
ventricular myocytes. Circulation 91:3010 3016. Scheygrond H, Reyntjens H. 1981. On the pharmacokinetics
27. Dumaine R, Roy ML, Brown AM. 1998. Blockade of HERG and of domperidone in animals and man. IV. The pharmacokinet-
Kv1.5 by ketoconazole. J Pharmacol Exp Ther 286:727 735. ics of intravenous domperidone and its bioavailability in man
28. Geelen P, Drolet B, Lessard E, Gilbert P, O Hara GE, Turgeon following intramuscular, oral and rectal administration. Eur J
J. 1999. Concomitant block of the rapid (I(Kr)) and slow [I(Ks)] Drug Metab Pharmacokinet 6:61 70.
components of the delayed rectifier potassium current is asso- 44. Schäfer-Korting M, Korting HC, Dorn M, Mutschler E. 1984.
ciated with additional drug effects on lengthening of cardiac Ketoconazole concentrations in human skin blister fluid and
repolarization. J Cardiovasc Pharmacol Ther 4:143 150. plasma. Int J Clin Pharmacol Ther Toxicol 22:371 374.
29. Fournier P, Pacouret G, Charbonnier B. 1993. A new cause of 45. Austin KL, Mather LE, Philpot CR, McDonald PJ. 1980. Inter-
torsades de pointes: Combination of terfenadine and trolean- subject and dose-related variability after intravenous admin-
domycin. Ann Cardiol Angeiol (Paris) 42:249 252 (in French). istration of erythromycin. Br J Clin Pharmacol 10:273 9.
30. Feroze H, Suri R, Silverman DI. 1996. Torsades de pointes 46. Allen MJ , Nichols DJ, Oliver SD. 2000. The pharmacokinet-
from terfenadine and sotalol given in combination. Pacing Clin ics and pharmacodynamics of oral dofetilide after twice daily
Electrophysiol 19:1519 1521. and three times daily dosing. Br J Clin Pharmacol 50:247
31. Yap YG, Camm AJ. 2003. Drug induced QT prolongation and 253.
torsades de pointes. Heart 89:1363 1372. 47. Roden DM, Reele SB, Higgins SB, Wilkinson GR, Smith
32. Abriel H, Schlapfer J, Keller DI, Gavillet B, Buclin T, Biollaz RF, Oates JA, Woosley RL. 1980. Antiarrhythmic efficacy,
J, Stoller R, Kappenberger L. 2004. Molecular and clinical de- pharmacokinetics and safety of N-acetylprocainamide in hu-
terminants of drug-induced long QT syndrome: An iatrogenic man subjects: comparison with procainamide. Am J Cardiol
channelopathy. Swiss Med Wkly 134:685 694. 46:463 468.
DOI 10.1002/jps JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 100, NO. 6, MAY 2011
[ Pobierz całość w formacie PDF ]